Hapten Sciences, Inc. — Form D
Hapten Sciences, Inc. of MEMPHIS, TN, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-31. The offering totals $1.5M, of which $886K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-10-31
- Form: D
- Accession: 0001526465-19-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $886K
- Remaining: $614K
- Investors: 4
- Date of first sale: 2019-10-21
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-352299
Issuer
- Name: Hapten Sciences, Inc.
- CIK: 0001526465
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 40 S. MAIN, SUITE 2300, MEMPHIS, TN, 38103
- Phone: 9017473946
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Stephen L Bandak | Director | Memphis, TN |
| Gary L Stevenson | Director | Memphis, TN |
| Gary Prosterman | Director | Memphis, TN |
| Gary Prosterman | Executive Officer | Memphis, TN |
| Gary Prosterman | Promoter | Memphis, TN |
| Joseph L Zakrzewski | Director | Memphis, TN |
| Gary I Stevenson | Director | Memphis, TN |
| Joseph I Zakrzewski | Director | Memphis, TN |
| Stephen I Bandak | Director | Memphis, TN |
| Raymond J Hage | Director | Memphis, TN |
| Raymond J Hage | Executive Officer | Memphis, TN |
| Raymond J Hage | Promoter | Memphis, TN |
Other filings by this issuer (13)
More